Introducing OneScan-SmartPass, a groundbreaking collaboration between LSPedia and Medical Value Chain (MVC). Built on the trusted foundation of LSPedia’s OneScan system and MVC’s blockchain-powered SmartPass platform, the Country-Hub L-5 solution provides a new standard for supply chain transparency and pharmaceutical security.
Counterfeit pharmaceuticals represent a $200 billion global crisis, threatening patient safety and undermining trust. OneScan-SmartPass addresses this challenge with a robust, blockchain-driven solution that ensures only legitimate products reach patients.
OneScan-SmartPass seamlessly integrates MVC’s patent-pending dual immutable distributed ledger technology with LSPedia’s proven compliance and traceability tools. Together, they deliver unparalleled capabilities for governments, manufacturers, distributors, and regulators to combat counterfeit pharmaceuticals and enhance public health security.
Comprehensive oversight of pharmaceuticals from import to consumer and back to the manufacturer.
Prevents counterfeit and unauthorized products from entering the supply chain.
Real-time data sharing to meet diverse international compliance requirements.
OneScanPass is designed for a wide range of stakeholders across the pharmaceutical supply chain. Government agencies can strengthen regulatory frameworks and enforce compliance, while pharmaceutical manufacturers ensure product authenticity and streamline cross-border exports. Distributors and wholesalers benefit from enhanced supply chain integrity, and healthcare providers safeguard patient safety with reliable and efficient traceability solutions.
Contact LSPedia“
OneScan SmartPass is more than technology; it's a commitment to creating a safer, more transparent pharmaceutical industry.”
Join the leaders in global traceability and patient safety. Discover how the L-5 Solution with OneScan-SmartPass can transform your supply chain.
Request a Demo